GlassScriptPhysician profile
Cameron Reynolds
NPI 1306509633
$2,555.15
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,020 · 2023: $1,299 · 2024: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,534.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $514.51 | 2022-2024 | Caplyta |
| Abbvie INC. | $494.68 | 2022-2023 | |
| Neurocrine Biosciences, INC. | $334.33 | 2022-2023 | Ingrezza |
| Janssen Pharmaceuticals, INC | $334.13 | 2022-2024 | Invega, Invega Sustenna, Invega Trinza |
| Alkermes, INC. | $232.71 | 2022-2023 | Aristada, Lybalvi |
| Otsuka America Pharmaceutical, INC. | $118.28 | 2022-2023 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $111.52 | 2022-2024 | Trintellix |
| Lundbeck LLC | $83.71 | 2023-2024 | Rexulti |
| Indivior INC. | $60.61 | 2022-2023 | Perseris |
| Sunovion Pharmaceuticals INC. | $60.43 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $58.26 | 2022-2023 | Uzedy, Austedo Xr |
| Bausch Health US, LLC | $56.20 | 2022 | |
| Ironshore Pharmaceuticals INC. | $39.78 | 2022-2023 | Jornay Pm |
| Corium, LLC | $25.23 | 2024 | Azstarys |
| Almatica Pharma LLC | $18.29 | 2023 | Gralise |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $12.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cameron Reynolds listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.